Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
about
Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Is Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350.New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies
P2860
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@en
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@nl
type
label
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@en
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@nl
prefLabel
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@en
Long-Term Outcomes after Treat ...... and Myelodysplastic Syndrome.
@nl
P2093
P2860
P1476
Long-Term Outcomes after Treat ...... a and Myelodysplastic Syndrome
@en
P2093
Amin M Alousi
Benigno C Valdez
Borje S Andersson
Elizabeth J Shpall
Gabriela Rondon
Haven R Garber
Julianne Chen
Laura L Worth
Marcos de Lima
P2860
P304
P356
10.1016/J.BBMT.2016.06.023
P577
2016-07-01T00:00:00Z